Skip to main content
Premium Trial:

Request an Annual Quote

Marligen Raises $2.3 Million

NEW YORK, May 10 (GenomeWeb News) - Marligen Biosciences said today that it has raised $2.3 million in funding through a Series A round of financing, as well as grants from government and non-profit agencies.

 

Among the company's investors in the financing round were Emerging Technology Partners and ASM Resources, Marligen said.

 

"We are delighted that our efforts to raise cash from several sources were successful," Marligen founder and CEO Sherry Challberg said in a statement. "In addition to completing our Series A financing, we also have been awarded a Maryland Department of Business & Economic Development Challenge grant, a MdBio Technology Accelerator Award, and a Phase II Small Business Innovation Research grant."

 

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.